Consequently, the activation of cancer-related signaling pathways such as AKT, ERK, AP-1, STAT3, and NF-kB was inhibited, leading to a blockade in tumor proliferation and invasion capabilities [44, 45]. This evidence concerns the gene NFKB1 and neoplasm.